340B Drug Pricing Program
We recently sent you a note asking for your help completing a form that will help with our advocacy efforts to push back against illegal actions several drug manufacturers are taking to limit 340B pricing to contract pharmacies. Thank you to those organizations that already have completed the form.
President Biden today submitted to Congress his budget request for fiscal year (FY) 2023.
AHA shares proposals to lower Medicare drug prices with congress.
The Senate last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year.
The House of Representatives last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year. The legislation also includes provisions beneficial to hospitals and health systems.
The House Appropriations Committee announced an agreement on omnibus appropriations legislation funding the federal government through the end of the current fiscal year.
AHA urges HHS to ensure hospitals participating in the 340B Drug Pricing Program do not lose access to the program as a result of changes in patterns of patient care due to the COVID-19 public health emergency (PHE).
Congress is back in Washington, D.C., and part of its focus will be passing a package that funds the federal government through October.
The COVID-19 pandemic has altered hospitals’ payer mix, which for some hospitals has temporarily lowered their
disproportionate share hospital (DSH) percentage. These changes have unfortunately threatened the ability of some
hospitals to maintain their eligibility for the 340B program – a vital…
Updates on 340B Legislation, Representatives Letter to HHS